Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromodomain Y-linked 11 pseudogene (CDY11P) is a noncoding genetic element on the human Y chromosome classified as a pseudogene, meaning it is homologous to a functional gene but carries mutations that prevent it from encoding a functional protein[1][7]. It belongs to the group of Y-linked chromodomain pseudogenes, homologous to chromodomain-containing proteins involved in chromatin regulation but does not carry out this function itself[7]. Pseudogenes like CDY11P can impact gene expression through regulatory RNA mechanisms—acting as competing endogenous RNAs (ceRNAs), microRNA decoys, or, rarely, generating regulatory RNAs[2][6][4]. There are currently no known drugs, therapeutic applications, or disease biomarkers associated with this pseudogene, and it is not considered a therapeutic target. Its name may sometimes appear in gene or pseudogene cataloging but it does not play a direct role in normal physiological processes or disease as a protein or classical molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromodomain Y-linked 11 pseudogene (CDY11P).